organic compounds
2,4-Dichloro-7-fluoroquinazoline
aDepartment of Chinese Traditional Herbs, Agromomy College, Sichuan Agricultural University, Chengdu 611130, People's Republic of China
*Correspondence e-mail: gaofeng@sicau.edu.cn
The molecule of the title compound, C8H3Cl2FN2, is essentially planar, with a maximum deviation of 0.018 (2) Å. In the crystal, π–π stacking is observed between parallel quinazoline moieties of adjacent molecules, the centroid–centroid distance being 3.8476 (14) Å.
Related literature
For the synthesis of quinazoline derivatives, see: Roberts et al. (2011); Gao et al. (2010); Li et al. (2009); Connolly et al. (2005). For the pharmacological properties of quinazoline analogues, see: Koller et al. (2011); Garofalo et al. (2011); Yang et al. (2011). For related structures, see: Jia et al. (2011); Ouahrouch et al. (2011).
Experimental
Crystal data
|
Data collection: CrysAlis PRO (Agilent, 2010); cell CrysAlis PRO; data reduction: CrysAlis PRO; program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL; molecular graphics: SHELXTL; software used to prepare material for publication: SHELXTL.
Supporting information
10.1107/S1600536812006125/xu5446sup1.cif
contains datablocks I, global. DOI:Structure factors: contains datablock I. DOI: 10.1107/S1600536812006125/xu5446Isup2.hkl
Supporting information file. DOI: 10.1107/S1600536812006125/xu5446Isup3.cml
2,4-Dichloro-7-fluoroquinazoline was synthesized presently through two steps reactions implying 2-amino-4-fluorobenzoic acid as the starting material: 1. Acetic acid (80 ml) was added to a suspension of 2-amino-4-fluorobenzoic acid (100 g, 0.645 mol) in water (2L), a solution of NaOCN (105 g, 1.616 mol) in water (800 ml) was added dropwise under vigorous stirring with a mechanical stirrer. The reaction mixture was stirred at room temperature for 30 min, and NaOH (480 g, 12 mol) was added in small portions, and the mixture was cooled to room temperature. Then concentrated HCl (~1.2L) was added dropwise to the reaction mixture to attain pH ~4 (strong foaming!). The formed precipitate was separated by filtration, washed with water, and air-dried to give compound 7-fluoroquinazoline-2,4(1H,3H)-dione (yield 82%, 95 g). It was used in the next step without any purification. 2. A mixture of compound 7-fluoroquinazoline-2,4(1H,3H)-dione (150 g, 0.83 mol), N,N-diethylaniline (125 g, 0.84 mol), and POCl3 (500 ml) was refluxed for overnight. Most of POCl3 was removed by rotary vapor. The residue was poured into the mixture water/ice (~4L), and the formed precipitate was separated by filtration, washed with water, and vacuum-dried to give compound 2,4-dichloro-7-fluoroquinazoline (yield 94%, 170 g). Single crystals of 2,4-dichloro-7-fluoroquinazoline, C8H3Cl2FN2, were recrystallized from acetone, mounted in inert oil and transferred to the cold gas stream of the diffractometer.
H atoms were placed in calculated positions and treated as riding atoms [C—H = 0.93–0.96 Å], with Uiso(H) = 1.5Ueq(C) for methyl H atoms and 1.2Ueq(C) for others.
Data collection: CrysAlis PRO (Agilent, 2010); cell
CrysAlis PRO (Agilent, 2010); data reduction: CrysAlis PRO (Agilent, 2010); program(s) used to solve structure: SHELXTL (Sheldrick, 2008); program(s) used to refine structure: SHELXTL (Sheldrick, 2008); molecular graphics: SHELXTL (Sheldrick, 2008); software used to prepare material for publication: SHELXTL (Sheldrick, 2008).Fig. 1. Molecular structure of showing 30% probability displacement ellipsoids. | |
Fig. 2. The packing viewed along c axis with π···π interactions, indicating the dimer. |
C8H3Cl2FN2 | F(000) = 432 |
Mr = 217.02 | Dx = 1.750 Mg m−3 |
Monoclinic, P21/n | Mo Kα radiation, λ = 0.71073 Å |
a = 3.8257 (3) Å | Cell parameters from 1033 reflections |
b = 15.0664 (9) Å | θ = 3.0–25.0° |
c = 14.3453 (6) Å | µ = 0.75 mm−1 |
β = 95.102 (5)° | T = 293 K |
V = 823.59 (9) Å3 | Block, brown |
Z = 4 | 0.35 × 0.30 × 0.25 mm |
Agilent Xcalibur Eos diffractometer | 1452 independent reflections |
Radiation source: Enhance (Mo) X-ray Source | 1120 reflections with I > 2σ(I) |
Graphite monochromator | Rint = 0.025 |
Detector resolution: 10.0 pixels mm-1 | θmax = 25.0°, θmin = 3.1° |
ω scans | h = −4→4 |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2010) | k = −15→17 |
Tmin = 0.780, Tmax = 0.835 | l = −16→16 |
3156 measured reflections |
Refinement on F2 | Primary atom site location: structure-invariant direct methods |
Least-squares matrix: full | Secondary atom site location: difference Fourier map |
R[F2 > 2σ(F2)] = 0.038 | Hydrogen site location: inferred from neighbouring sites |
wR(F2) = 0.095 | H-atom parameters constrained |
S = 1.07 | w = 1/[σ2(Fo2) + (0.0389P)2] where P = (Fo2 + 2Fc2)/3 |
1452 reflections | (Δ/σ)max < 0.001 |
118 parameters | Δρmax = 0.20 e Å−3 |
0 restraints | Δρmin = −0.23 e Å−3 |
C8H3Cl2FN2 | V = 823.59 (9) Å3 |
Mr = 217.02 | Z = 4 |
Monoclinic, P21/n | Mo Kα radiation |
a = 3.8257 (3) Å | µ = 0.75 mm−1 |
b = 15.0664 (9) Å | T = 293 K |
c = 14.3453 (6) Å | 0.35 × 0.30 × 0.25 mm |
β = 95.102 (5)° |
Agilent Xcalibur Eos diffractometer | 1452 independent reflections |
Absorption correction: multi-scan (CrysAlis PRO; Agilent, 2010) | 1120 reflections with I > 2σ(I) |
Tmin = 0.780, Tmax = 0.835 | Rint = 0.025 |
3156 measured reflections |
R[F2 > 2σ(F2)] = 0.038 | 0 restraints |
wR(F2) = 0.095 | H-atom parameters constrained |
S = 1.07 | Δρmax = 0.20 e Å−3 |
1452 reflections | Δρmin = −0.23 e Å−3 |
118 parameters |
Geometry. All e.s.d.'s (except the e.s.d. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell e.s.d.'s are taken into account individually in the estimation of e.s.d.'s in distances, angles and torsion angles; correlations between e.s.d.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell e.s.d.'s is used for estimating e.s.d.'s involving l.s. planes. |
Refinement. Refinement of F2 against ALL reflections. The weighted R-factor wR and goodness of fit S are based on F2, conventional R-factors R are based on F, with F set to zero for negative F2. The threshold expression of F2 > σ(F2) is used only for calculating R-factors(gt) etc. and is not relevant to the choice of reflections for refinement. R-factors based on F2 are statistically about twice as large as those based on F, and R- factors based on ALL data will be even larger. |
x | y | z | Uiso*/Ueq | ||
Cl1 | 0.18763 (19) | 0.24582 (4) | 0.86579 (4) | 0.0500 (3) | |
Cl2 | 0.2734 (2) | 0.09054 (5) | 0.54819 (5) | 0.0628 (3) | |
F1 | 0.8584 (4) | 0.55046 (10) | 0.60324 (11) | 0.0652 (5) | |
N1 | 0.2491 (5) | 0.17987 (14) | 0.70176 (14) | 0.0416 (5) | |
N2 | 0.4812 (5) | 0.25290 (13) | 0.57255 (14) | 0.0389 (5) | |
C1 | 0.3448 (6) | 0.18701 (17) | 0.61375 (17) | 0.0392 (6) | |
C2 | 0.3050 (6) | 0.25134 (16) | 0.75263 (17) | 0.0360 (6) | |
C3 | 0.4494 (6) | 0.33043 (16) | 0.72000 (16) | 0.0331 (6) | |
C4 | 0.5323 (6) | 0.32793 (16) | 0.62626 (16) | 0.0327 (6) | |
C5 | 0.6758 (7) | 0.40354 (16) | 0.58670 (16) | 0.0389 (6) | |
H5 | 0.7365 | 0.4030 | 0.5253 | 0.047* | |
C6 | 0.7228 (7) | 0.47677 (17) | 0.64004 (19) | 0.0428 (7) | |
C7 | 0.6403 (7) | 0.48233 (17) | 0.73259 (19) | 0.0455 (7) | |
H7 | 0.6783 | 0.5346 | 0.7665 | 0.055* | |
C8 | 0.5030 (7) | 0.40973 (16) | 0.77230 (17) | 0.0426 (7) | |
H8 | 0.4443 | 0.4122 | 0.8338 | 0.051* |
U11 | U22 | U33 | U12 | U13 | U23 | |
Cl1 | 0.0595 (5) | 0.0612 (5) | 0.0313 (4) | 0.0047 (4) | 0.0158 (3) | 0.0092 (3) |
Cl2 | 0.0870 (6) | 0.0476 (5) | 0.0541 (5) | −0.0111 (4) | 0.0086 (4) | −0.0150 (4) |
F1 | 0.0783 (13) | 0.0466 (10) | 0.0717 (12) | −0.0159 (9) | 0.0123 (10) | 0.0132 (9) |
N1 | 0.0454 (14) | 0.0428 (13) | 0.0367 (12) | −0.0035 (11) | 0.0043 (10) | 0.0014 (11) |
N2 | 0.0455 (13) | 0.0404 (13) | 0.0314 (11) | −0.0004 (11) | 0.0074 (10) | −0.0032 (10) |
C1 | 0.0433 (16) | 0.0373 (15) | 0.0369 (14) | 0.0015 (13) | 0.0029 (12) | −0.0033 (12) |
C2 | 0.0330 (14) | 0.0469 (16) | 0.0285 (12) | 0.0071 (12) | 0.0045 (11) | 0.0052 (12) |
C3 | 0.0320 (14) | 0.0385 (14) | 0.0286 (12) | 0.0057 (12) | 0.0022 (11) | 0.0039 (11) |
C4 | 0.0301 (14) | 0.0365 (14) | 0.0315 (13) | 0.0033 (12) | 0.0019 (11) | 0.0037 (11) |
C5 | 0.0427 (16) | 0.0437 (16) | 0.0311 (13) | 0.0022 (13) | 0.0074 (12) | 0.0037 (12) |
C6 | 0.0389 (15) | 0.0397 (16) | 0.0493 (16) | −0.0033 (13) | 0.0008 (13) | 0.0123 (14) |
C7 | 0.0504 (17) | 0.0370 (15) | 0.0485 (16) | 0.0004 (13) | 0.0013 (13) | −0.0069 (13) |
C8 | 0.0469 (17) | 0.0478 (16) | 0.0336 (14) | 0.0060 (14) | 0.0066 (12) | −0.0037 (13) |
Cl1—C2 | 1.724 (2) | C3—C8 | 1.416 (3) |
Cl2—C1 | 1.739 (3) | C4—C5 | 1.406 (3) |
F1—C6 | 1.352 (3) | C5—C6 | 1.346 (3) |
N1—C2 | 1.308 (3) | C5—H5 | 0.9300 |
N1—C1 | 1.350 (3) | C6—C7 | 1.394 (4) |
N2—C1 | 1.289 (3) | C7—C8 | 1.360 (3) |
N2—C4 | 1.372 (3) | C7—H7 | 0.9300 |
C2—C3 | 1.411 (3) | C8—H8 | 0.9300 |
C3—C4 | 1.409 (3) | ||
C2—N1—C1 | 114.3 (2) | C5—C4—C3 | 119.5 (2) |
C1—N2—C4 | 114.9 (2) | C6—C5—C4 | 118.2 (2) |
N2—C1—N1 | 130.1 (2) | C6—C5—H5 | 120.9 |
N2—C1—Cl2 | 116.50 (18) | C4—C5—H5 | 120.9 |
N1—C1—Cl2 | 113.36 (19) | C5—C6—F1 | 119.2 (2) |
N1—C2—C3 | 124.0 (2) | C5—C6—C7 | 124.1 (2) |
N1—C2—Cl1 | 116.25 (18) | F1—C6—C7 | 116.7 (2) |
C3—C2—Cl1 | 119.70 (18) | C8—C7—C6 | 118.6 (2) |
C4—C3—C2 | 115.0 (2) | C8—C7—H7 | 120.7 |
C4—C3—C8 | 119.6 (2) | C6—C7—H7 | 120.7 |
C2—C3—C8 | 125.4 (2) | C7—C8—C3 | 120.0 (2) |
N2—C4—C5 | 118.8 (2) | C7—C8—H8 | 120.0 |
N2—C4—C3 | 121.7 (2) | C3—C8—H8 | 120.0 |
Experimental details
Crystal data | |
Chemical formula | C8H3Cl2FN2 |
Mr | 217.02 |
Crystal system, space group | Monoclinic, P21/n |
Temperature (K) | 293 |
a, b, c (Å) | 3.8257 (3), 15.0664 (9), 14.3453 (6) |
β (°) | 95.102 (5) |
V (Å3) | 823.59 (9) |
Z | 4 |
Radiation type | Mo Kα |
µ (mm−1) | 0.75 |
Crystal size (mm) | 0.35 × 0.30 × 0.25 |
Data collection | |
Diffractometer | Agilent Xcalibur Eos diffractometer |
Absorption correction | Multi-scan (CrysAlis PRO; Agilent, 2010) |
Tmin, Tmax | 0.780, 0.835 |
No. of measured, independent and observed [I > 2σ(I)] reflections | 3156, 1452, 1120 |
Rint | 0.025 |
(sin θ/λ)max (Å−1) | 0.594 |
Refinement | |
R[F2 > 2σ(F2)], wR(F2), S | 0.038, 0.095, 1.07 |
No. of reflections | 1452 |
No. of parameters | 118 |
H-atom treatment | H-atom parameters constrained |
Δρmax, Δρmin (e Å−3) | 0.20, −0.23 |
Computer programs: CrysAlis PRO (Agilent, 2010), SHELXTL (Sheldrick, 2008).
Acknowledgements
This project was supported by the NSFC (grant No. 81001383) and the Doctoral Foundation of the Ministry of Education, China (grant No. 20105103120009).
References
Agilent (2010). CrysAlis PRO. Agilent Technologies, Yarnton, Oxfordshire, England. Google Scholar
Connolly, T. J., McGarry, P. & Sukhtankar, S. (2005). Green Chem. 7, 586–589. Web of Science CrossRef CAS Google Scholar
Gao, J., He, L.-N., Miao, C.-X. & Chanfreau, S. B. (2010). Tetrahedron, 66, 4063–4067. Web of Science CrossRef CAS Google Scholar
Garofalo, A., Goossens, L., Six, P., Lemoine, A., Ravez, S., Farce, A. & Depreux, P. (2011). Bioorg. Med. Chem. Lett. 21, 2106–2112. Web of Science CrossRef CAS PubMed Google Scholar
Jia, J., Wang, G. & Lu, D. (2011). Acta Cryst. E67, o229. Web of Science CSD CrossRef IUCr Journals Google Scholar
Koller, M., Lingenhoehl, K., Schmutz, M., Vranesic, I.-T., Kallen, J., Auberson, Y. P., Carcache, D. A., Mattes, H., Ofner, S., Orain, D. & Urwyler, S. (2011). Bioorg. Med. Chem. Lett. 21, 3358–3361. Web of Science CrossRef CAS PubMed Google Scholar
Li, J.-R., Chen, X., Shi, D.-X., Ma, S.-L., Li, Q., Zhang, Q. & Tang, J.-H. (2009). Org. Lett. 11, 1193–1196. Web of Science PubMed CAS Google Scholar
Ouahrouch, A., Lazrek, H. B., Taourirte, M., El Azhari, M., Saadi, M. & El Ammari, L. (2011). Acta Cryst. E67, o2029–o2030. Web of Science CSD CrossRef IUCr Journals Google Scholar
Roberts, B., Liptrot, D., Luker, T., Stocks, M. J., Barber, C., Webb, N., Dods, R. & Martin, B. (2011). Tetrahedron Lett. 52, 3793–3796. Web of Science CrossRef CAS Google Scholar
Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. Web of Science CrossRef CAS IUCr Journals Google Scholar
Yang, S. H., Khadka, D. B., Cho, S. H., Ju, H. K., Lee, Y. K., Han, J. H., Lee, K. T. & Cho, W. J. (2011). Bioorg. Med. Chem. 19, 968–977. Web of Science CrossRef CAS PubMed Google Scholar
This is an open-access article distributed under the terms of the Creative Commons Attribution (CC-BY) Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.
As the important six-membered heterocycles, quinazoline derivatives have always drawn the attention of organic and medicinal chemists for their various biological activities and significant synthetic materials. Several quinazoline-containing compounds have been approved by FDA, such as EGFR inhibitors Iressa and Tarceva used in the treatment of cancer, as well as alpha adrenergic receptor antagonists Praosin and Alfuzosine, which have been used for anti-hypertensive drugs in clinic. In addition, quinazoline derivatives also have been reported as anti-inflammatory, antibacterial or anticonvulsant agents. Most recently, quinazoline analogues have been found as selective VEGFR-2 receptor tyrosine kinase inhibitors, novel heat shock protein 90 inhibitors, EGFR Tyrosine kinase inhibitors, as well as glucocerebrosidase inhibitors.